65,437 trials
Adrenal Hyperplasia, Congenital
Primary: Percent Difference in the Mean Log Transformed Area Under the Curve of 17-hydroxyprogesterone Between Regimens — 3.16; 3.91 Log Mean Area Under the Curve — p=0.09
Hypogonadism
Primary: Time-average (Cavg) Steady State Testosterone Concentration Over 24 Hours — 463 ng/dL
Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer
Primary: Progression-free Survival (PFS) Time - Independent Review Committee (IRC) Assessments — 8.9; 8.0 months — p=0.0479
Melanoma
Primary: Progression Free Survival (PFS) — 122; 125 days — p=0.492
Carcinoma, Non-Small-Cell Lung
Primary: Best Disease Response After a Maximum of Six Cycles. — 0; 23; 23; 6 Participants
Nasolabial Folds
Primary: Treatment Difference in Pain as Measured by a Visual Analogue Scale — 44.9; 14.7 Scores on a VAS Scale
Neoplasms, Breast
Primary: Percentage of Participants With Progressive Disease at Week 12 in Cohort 1 — 38.9; 36.2; 43.1; 37.7 percentage of participants — p=0.3724
Depression · Major Depressive Disorder
Primary: Number of Participants With Adverse Events AEs) and Serious Adverse Events (SAEs) — 0; 0; 0; 0 participants
Allergy
Primary: Average Daily Asthma Medication Score During a 2-months Evaluation Period in Autumn 2008 — 4.4; 4.7 Scores on a scale — p=0.85
Healthy
Primary: Cmax of Donepezil. — 15627.68; 15687.09 ng/mL
Diabetes Mellitus, Type 2
Primary: INITIATION: 24-Week Endpoint Glycosylated Hemoglobin (HbA1c) — 7.33; 7.23 percent glycosylated hemoglobin — p=0.005
Heart Diseases · Heart Transplantation
Primary: The Change in the Markers of Growth, Apoptosis, Inflammation and Oxidation Measured in Endomyocardial Biopsies — 0.70; 0.90; 0.87; 0.79 Densitometry / Densitometry of…
Cutaneous B-cell Non-Hodgkin Lymphoma · Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue · Intraocular Lymphoma
Primary: Number of Patients With Objective Response — 10; 8 participants
Healthy
Primary: Cmax of Fluoxetine. — 75.32; 69.86 ng/mL
Epilepsies, Partial
Primary: Response Ratio of Gabapentin in Japanese Pediatric Patients With Partial Seizures — -0.158 ratio